Advanced Medical Solutions Group plc announced the appointment of Peter Allen as a Non-Executive Director effective from 4 December 2013. He will then become Non-Executive Chairman from 1 January 2014, replacing Dr. Don Evans who will retire from the Board on 31 December 2013. Mr. Allen, aged 57, has extensive experience in the healthcare industry, having held key senior positions in a number of companies, playing a significant role in their development.

This includes 12 years at Celltech Group plc (1992-2004) as CFO and Deputy CEO, 5 years as Chairman (since 2007) and interim CEO (2010-11) of ProStrakan Group plc, and 3 years as Chairman of Proximagen Neurosciences plc (2009-12). All of these companies, through a mix of organic growth, acquisitions and partnership agreements, saw significant increases in shareholder value during the periods in question. Mr. Allen is currently Non-Executive Chairman of Future plc and Clinigen plc, as well as Chroma Therapeutics Limited and ProStrakan Group plc, although he will be stepping down as Non-Executive Chairman of the latter on 31 December 2013.

Mr. Allen is also a Non-Executive Director of Mecom plc, Scancell plc and Oxford Nanopore Technologies Limited. He is a qualified chartered accountant.